ARCHIVES

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Committee Approves Concepts For Studies In Special Populations

December 11, 1987

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993

Eight Win ASCO Young Investigator Awards

August 22, 1986

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001